Improving the accuracy of lung cancer nodal staging before treatment
Comparative-Effectiveness of Pretreatment Lung Cancer Nodal Staging
This study is looking at the best ways to find out if lung cancer has spread to lymph nodes, which is really important for choosing the right treatment, so we can help lung cancer patients get the care they need to live longer and healthier lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11007220 on NIH RePORTER |
What this research studies
This research aims to enhance the accuracy of determining whether lung cancer has spread to lymph nodes, which is crucial for selecting the appropriate treatment. By comparing the effectiveness of different methods for nodal staging, including imaging and biopsy, the study seeks to reduce diagnostic errors that can lead to inadequate or excessive treatment. The research will analyze current practices and variability in biopsy rates to identify the best approaches for patient care. Ultimately, the goal is to improve survival rates and the overall value of care for lung cancer patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are lung cancer patients who require nodal staging to determine the extent of their disease.
Not a fit: Patients who have already undergone treatment or those with non-cancerous conditions will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate treatment decisions for lung cancer patients, potentially improving survival rates.
How similar studies have performed: Previous research has indicated that improving nodal staging accuracy can significantly impact treatment outcomes, suggesting that this approach has the potential for success.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Farjah, Farhood — University of Washington
- Study coordinator: Farjah, Farhood
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.